21.
Safety and immunogenicity of ALVAC wild-type human p53 (vCP207) by the intravenous route in rhesus macaques
by Rosenwirth, Brigitte
Vaccine, 2001, Vol.19 (13), p.1661-1670
22.
In vitro replication of SIVcpz is suppressed by β-chemokines and CD8+ T cells but not by natural killer cells of infected chimpanzees
by ONDOA, Pascale
AIDS research and human retroviruses, 2002, Vol.18 (5), p.373-382
23.
HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees
by Bruck, Claudine
Vaccine, 1994, Vol.12 (12), p.1141-1148
24.
Characterization of alpha -Defensins Plasma Levels in Macaca fascicularis and Correlations with Virological Parameters during SHIV89.6P sub(Cy11) Experimental Infection
by Baroncelli, S
AIDS research and human retroviruses, 2007-02-01, Vol.23 (3), p.287-296
25.
European contribution to the science, prevention and management of HIV infection
by Lehner, T
Vaccine, 1997, Vol.15 (5), p.465-468
26.
In Vitro Replication of SIVcpz Is Suppressed by beta -Chemokines and CD8 super(+) T Cells But Not by Natural Killer Cells of Infected Chimpanzees
by Ondoa, P
AIDS research and human retroviruses, 2002-03-20, Vol.18 (5), p.373-382
27.
Production and related variables in bovine leukaemia virus-infected cows
by Jacobs, R.M. (Guelph Univ., Guelph, Ont. (Canada). Dept. of Pathology)
Veterinary research communications, 1991, Vol.15 (6), p.463-474
28.
29.
The relative resistance of HIV type 1-infected chimpanzees to AIDS correlates with the maintenance of follicular architecture and the absence of infiltration by CD8 super(+) cytoto...
by Koopman, G
AIDS research and human retroviruses, 1999-03-01, Vol.15 (4), p.365-373
